OSR Holdings, Inc. (NASDAQ:OSRH) Financings
Financings
| Raise | Date |
|---|---|
| Strategic investment of common stock Announced: up to US$15M · US$10 a share Buyers: BCME (may be required to purchase up to $15 million of OSRH common stock at $10.00 per share) Insiders: BCME, the company's largest shareholder, would be the purchaser under the put option; the agreement is a related party transaction approved by the Board including independent directors. | Apr 29, 2026 |
| Convertible promissory note Closed: US$555,555 raised Buyers: White Lion GBM Innovation Fund Use of proceeds: Near-term liquidity for general corporate purposes and continued execution of strategic priorities | Apr 9, 2026 |
| Private placement of oSRT security tokens Announced: up to US$50M Buyers: BCM Europe AG (anticipated participation, subscribing with BTC or USDT rather than TAC) Use of proceeds: Part of a path toward building a $100 million Bitcoin and USDT reserve on the balance sheet | Jul 8, 2025 |
| Common stock Announced: up to US$80M Buyers: White Lion GBM Innovation Fund (up to $80 million in common stock over time, at OSR's option) Use of proceeds: Advance its Vaximm immunotherapy platform (GBM vaccine VXM01) and other innovative healthcare solutions | Apr 3, 2025 |